Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus)

International Journal of Experimental Pathology

Volumn 89, Issue 3, 2008, Pages 171-179

  Lever, Mark S ^a   Stagg, Anthony J ^a   Nelson, Michelle ^a   Pearce, Peter ^a   Stevens, Daniel J ^a   Scott, Elizabeth A M ^a   Simpson, Andrew J H ^a   Fulop, Mark J ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

Bacillus anthracis; Inhalational; Marmoset

Indexed keywords

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL STRAIN; CALLITHRIX JACCHUS; CONTROLLED STUDY; EXPOSURE; FEMALE; LD 50; MALE; MARMOSET; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RHESUS MONKEY;

AEROSOLS; ANIMALS; ANTHRAX; BACILLUS ANTHRACIS; BODY WEIGHT; CALLITHRIX; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FEMALE; INHALATION EXPOSURE; LETHAL DOSE 50; MALE; RESPIRATORY TRACT INFECTIONS; VIRULENCE;

EID: 43349095129     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2008.00581.x     Document Type: Article

References (42)

1. Abramova F.A., Grinberg L.M., Yampolskaya O.V., Walker D.H. (1993) Pathology of inhalational anthrax in 42 cases from the Sverdlosk outbreak of 1979. Proc. Natl. Acad. Sci. 90, 2291 2294.
2. Albrink W.S. Goodlow R.J. (1959) Experimental inhalation anthrax in Chimpanzee. Am. J. Path. 35, 1055 1059.
3. Albrink W.S., Brooks S.M., Biron R.E., Kopel M. (1960) Human inhalation anthrax. Am. J. Path. 36, 457 471.
4. Belton F.C., Darlow H.M., Henderson D.W. (1956) The use of anthrax antigen to immunise man and monkey. Lancet 8, 476 479.
5. Bergers W.A., van de Meent-van der Horst D., Joosen M.J.A. (2004) Respiration-based measurment of a lung deposition of a fluorescent dextrane aerosol in a marmoset monkey. Inhal. Tox. 16, 141 146.
6. Brachman P.S., Kaufmann A.F., Dalldorf F.G. (1966) Industrial inhalation anthrax. Bact. Rev. 30, 646 657.
7. Dalldorf F.G. Kaufmann A. (1966) Studies on Inhalation Anthrax: III. Morphologic Studies. Technical manuscript 290, Fort Detrick: United States Army Biological Center.
8. Dixon W.J. Fotheringhamn N. (1993) Application of staircase bioassays in pharmaceutical research. Drug Info. J. 27, 741 751.
9. Druett H.A. (1969) A mobile form of the Henderson apparatus. J. Hyg. 67, 437 448.
10. Druett H.A., Henderson D.W., Packman L., Peacock S. (1953) Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores. J. Hyg. 51, 359 371.
11. Fellows P.F., Linscott M.K., Ivins B.E. et al. (2001) Efficacy of a human anthrax vaccine in guinea pigs, rabbits and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine 19, 3241 3247.
12. Fellows P.F., Linscott M.K., Little S.F. et al. (2002) Anthrax vaccine efficacy in golden Syrian hamsters. Vaccine 20, 1421 1424.
13. Flick-Smith H.C., Walker N.J., Gibson P. et al. (2002) A recombinant carboxy terminal domain of protective antigen of Bacillus anthracis protects mice against anthrax infection. Infect. Immun. 70, 1653 1656.
14. Flick-Smith H.C., Waters E.L., Walker N.J. et al. (2005) Mouse model characterisation for anthrax vaccine development: comparison of an inbred and an outbred mouse strain. Microb. Pathog. 38, 33 40.
15. Friedlander A.M., Welkos S.L., Pitt M.L.M. et al. (1993) Postexposure prophylaxis against experimental inhalation anthrax. J. Infect. Dis. 167, 1239 1242.
16. Fritz D.L., Jaxx N.K., Lawrence W.B. et al. (1995) Pathology of experimental inhalation anthrax in the rhesus monkey. Lab. Invest. 73, 691 702.
17. Glassman H.N. (1966) Industrial inhalation of anthrax; discussion. Bact. Rev. 30, 657 659.
18. Griffiths G.D., Hornby R.J., Jagger C.P. et al. (2006) Development of methods to measure humoral immune responses against selected antigens in the common marmoset (Callithrix jacchus) and the effect of pyridostigmine bromide administration. Int. Immunopharm. 6, 1755 1764.
19. Henderson D.W. (1952) An apparatus for the study of airborne infection. J. Hyg. (Camb.) 50, 53 68.
20. Henderson D.W., Peacock S., Belton F.C. (1956) Observations on the prophylaxis of experimental pulmonary anthrax in monkeys. J. Hyg 54, 2836.
21. Hornby R.J., Pearce P.C., Bowditch A.P. et al. (2006) Multiple vaccine and pyridostigmine bromide interactions in the common marmoset Callithrix jacchus: immunological and endocrinological effects. Int. Immunopharm. 6, 1765 1779.
22. Ivins B.E., Welkos S.L., Little S.F. et al. (1992) Immunisation against anthrax with Bacillus anthracis protective antigen combined with adjuvants. Infect. Immun. 60, 662 668.
23. Ivins B.E., Fellows P.F., Nelson G.O. (1994) Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea pigs. Vaccine 12, 872 874.
24. Ivins B.E., Fellows P.F., Pitt M.L.M. et al. (1996) Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in rhesus monkeys. Salisbury Med. Bull. 87, 125 126.
25. Ivins B.E., Pitt M.L., Fellows P.F. et al. (1998) Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in Rhesus macaques. Vaccine 16, 1141 1148.
26. Jones M.N., Beedham R.J., Turnbull P.C.B. et al. (1996) Efficacy of the UK human anthrax vaccine in guinea pigs against aerosolised spores of Bacillus anthracis. Salisbury Med. Bull. 87 (Suppl. 127 128.
27. Little S.F. Knudson G.B. (1986) Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Infect. Immun. 52, 509 512.
28. May K.R. (1973) The Collison nebuliser: description, performance and application. Aero. Sci 4, 235 243.
29. McBride B.W., Mogg A., Telfer J.L. et al. (1998) Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers. Vaccine 16, 810 817.
30. Pitt M.L., Little S., Ivins B.E. et al. (2001) In vitro correlate of immunity in an animal model of inhalational anthrax. Vaccine 19, 4768 4773.
31. Ross J.M. (1955) On the histopathology of experimental anthrax in the guinea pig. Br. J. Exp. Pathol. 36, 336 339.
32. Rowland C.A., Williamson E.D., Jones S.M. (2001) Intracellular detection of PA-specific IL4 following immunisation with a novel and current anthrax vaccines in Rhesus Macaques. In: Proceedings of the 4th International Conference on Anthrax, p. 46, Maryland: Annapolis.
33. Smith D., Trennery P., Farningham D., Klapwijk J. (2001) The selection of marmoset monkeys (Callithrix jacchus) in pharmaceutical toxicology. Lab. Anim. 35, 117 130.
34. Soviet Biological Warfare Threat 1986). Washington DC: Defence Intelligence Agency, US Dept of Defence 1986; Publication DST-161OF-057-86.
35. Turnbull P.C. (1986) Anthrax vaccines: past, present and future. Vaccine 9, 533 539.
36. Turnbull P.C.B., Broster M.G., Carman J.A. et al. (1986) Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infect. Immun. 52, 356 363.
37. Turnbull P.C.B., Leppla S.H., Broster M.G. et al. (1988) Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective antigen. Med. Microbiol. Immunol. 177, 293 303.
38. Varughese M., Teixeira A.V., Liu S., Leppla S.H. (1999) Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin. Infect. Immun. 67, 1860 1865.
39. Vasconcelos D., Barnewall R., Babin M. et al. (2003) Pathology of inhalation anthrax in cynomologus monkeys (Macaca fascilaris). Lab. Invest. 83, 1201 1209.
40. Welkos S.L., Keener T.J., Gibbs P.H. (1986) Differences in susceptibility of inbred mice to Bacillus anthracis. Infect. Immun. 51, 795 800.
41. Williamson E.D., Hodgson I., Walker N.J. et al. (2005) Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax. Infect. Immun. 73, 5978 5987.
42. Zaucha G.M., Pitt L.M., Estep J. et al. (1998) The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation Arch. Path. Lab. Med. 122, 982 992.